| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,458 |
4,970 |
$1.08M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
6,547 |
6,115 |
$910K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,343 |
2,203 |
$853K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
4,677 |
3,807 |
$311K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,757 |
2,582 |
$304K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,735 |
1,027 |
$196K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,202 |
460 |
$182K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,743 |
1,636 |
$130K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
560 |
545 |
$111K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,892 |
1,690 |
$80K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,240 |
1,975 |
$79K |
| 71046 |
Radiologic examination, chest; 2 views |
1,830 |
1,772 |
$70K |
| 70450 |
Computed tomography, head or brain; without contrast material |
461 |
446 |
$49K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,673 |
502 |
$48K |
| 71045 |
Radiologic examination, chest; single view |
935 |
894 |
$42K |
| 86886 |
|
1,523 |
1,456 |
$34K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
650 |
627 |
$30K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
113 |
113 |
$29K |
| 80061 |
Lipid panel |
2,631 |
2,582 |
$26K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,746 |
1,719 |
$25K |
| 62323 |
|
64 |
49 |
$25K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
415 |
414 |
$24K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,237 |
3,163 |
$23K |
| 80053 |
Comprehensive metabolic panel |
9,855 |
8,862 |
$22K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
174 |
172 |
$20K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
694 |
667 |
$19K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
11,228 |
9,897 |
$19K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
101 |
100 |
$17K |
| 73630 |
|
691 |
660 |
$15K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
203 |
185 |
$12K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
823 |
814 |
$11K |
| 36415 |
Collection of venous blood by venipuncture |
12,400 |
10,664 |
$11K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
775 |
767 |
$11K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
822 |
800 |
$10K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
544 |
192 |
$10K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,869 |
2,610 |
$8K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,804 |
1,776 |
$8K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
43 |
42 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,845 |
2,564 |
$5K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
227 |
226 |
$5K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
336 |
336 |
$5K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
128 |
116 |
$5K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,422 |
1,320 |
$4K |
| 84439 |
|
1,047 |
1,025 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,797 |
1,537 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,316 |
2,194 |
$4K |
| 87634 |
|
75 |
75 |
$3K |
| 85027 |
|
1,890 |
1,757 |
$3K |
| 01936 |
|
62 |
59 |
$3K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
86 |
83 |
$3K |
| 01967 |
Neuraxial labor analgesia/anesthesia for planned vaginal delivery |
13 |
12 |
$3K |
| 76830 |
Ultrasound, transvaginal |
57 |
56 |
$3K |
| 87070 |
|
848 |
833 |
$3K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
71 |
46 |
$2K |
| 87660 |
|
296 |
294 |
$2K |
| 87480 |
|
295 |
293 |
$2K |
| 87510 |
|
295 |
293 |
$2K |
| 83735 |
|
3,968 |
3,516 |
$2K |
| 88142 |
|
202 |
202 |
$2K |
| 82607 |
|
279 |
277 |
$2K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
28 |
24 |
$2K |
| 80305 |
|
1,173 |
1,098 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
173 |
172 |
$2K |
| 01992 |
|
89 |
80 |
$2K |
| 97162 |
|
26 |
25 |
$2K |
| 84702 |
|
455 |
360 |
$2K |
| 73130 |
|
78 |
78 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
185 |
184 |
$1K |
| 73562 |
|
50 |
50 |
$991.38 |
| 85610 |
|
2,329 |
2,012 |
$865.72 |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
45 |
41 |
$863.80 |
| 81001 |
|
2,552 |
2,326 |
$831.95 |
| 86900 |
|
1,710 |
1,623 |
$822.07 |
| 81003 |
|
2,396 |
2,303 |
$719.70 |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
42 |
42 |
$657.97 |
| 73030 |
|
25 |
25 |
$654.42 |
| 84100 |
|
2,386 |
2,181 |
$646.92 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
527 |
518 |
$644.82 |
| 87186 |
|
254 |
241 |
$617.95 |
| 87340 |
|
225 |
224 |
$612.37 |
| 86762 |
|
158 |
157 |
$589.02 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
104 |
97 |
$550.44 |
| 72110 |
|
12 |
12 |
$530.89 |
| 73610 |
|
26 |
26 |
$521.56 |
| 87503 |
|
77 |
77 |
$511.87 |
| 86592 |
|
186 |
185 |
$483.51 |
| 87653 |
|
26 |
25 |
$412.33 |
| 83880 |
|
471 |
450 |
$404.26 |
| 86901 |
|
1,733 |
1,645 |
$378.92 |
| 83690 |
|
2,382 |
2,226 |
$352.93 |
| 86140 |
|
400 |
344 |
$341.84 |
| 85730 |
|
1,288 |
1,211 |
$326.53 |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
24 |
24 |
$317.44 |
| 87081 |
|
68 |
68 |
$301.30 |
| 83605 |
|
2,433 |
2,173 |
$286.00 |
| 81025 |
|
1,833 |
1,765 |
$284.16 |
| 83540 |
|
81 |
81 |
$261.99 |
| 82550 |
|
1,381 |
1,040 |
$259.59 |
| 82150 |
|
1,205 |
1,135 |
$173.10 |
| 84484 |
|
2,083 |
1,523 |
$127.47 |
| 82565 |
|
43 |
38 |
$107.19 |
| 87077 |
|
13 |
13 |
$60.30 |
| 81015 |
|
334 |
317 |
$54.71 |
| 82950 |
|
18 |
18 |
$37.90 |
| 84520 |
|
16 |
12 |
$35.57 |
| 87040 |
|
53 |
52 |
$22.20 |
| 83516 |
|
21 |
13 |
$17.60 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,604 |
3,234 |
$10.15 |
| 85018 |
|
12 |
12 |
$7.99 |
| 85014 |
|
12 |
12 |
$7.99 |
| 85379 |
|
46 |
45 |
$7.68 |
| 85651 |
|
12 |
12 |
$6.81 |
| 85652 |
|
18 |
13 |
$6.42 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,564 |
1,514 |
$3.52 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,824 |
3,583 |
$3.14 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,583 |
1,454 |
$2.22 |
| J2704 |
Injection, propofol, 10 mg |
1,712 |
1,650 |
$2.20 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,862 |
2,590 |
$1.40 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,673 |
1,614 |
$0.01 |
| J7050 |
Infusion, normal saline solution, 250 cc |
262 |
207 |
$0.00 |
| A9270 |
Non-covered item or service |
2,361 |
1,448 |
$0.00 |
| J3490 |
Unclassified drugs |
2,380 |
1,505 |
$0.00 |
| 84703 |
|
13 |
13 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
279 |
257 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
44 |
39 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
17 |
14 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
40 |
38 |
$0.00 |
| G0378 |
Hospital observation service, per hour |
13 |
13 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
12 |
12 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
23 |
12 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
822 |
803 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
273 |
266 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
191 |
171 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$0.00 |
| 82948 |
|
23 |
12 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
71 |
66 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
14 |
12 |
$0.00 |